Avecho Biotechnology (ASX:AVE) Other Current Receivables : A$1.10 Mil (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Avecho Biotechnology Other Current Receivables?

Avecho Biotechnology's Other Current Receivables for the quarter that ended in Dec. 2023 was A$1.10 Mil.

Avecho Biotechnology's quarterly Other Current Receivables declined from Dec. 2022 (A$0.75 Mil) to Jun. 2023 (A$0.00 Mil) but then increased from Jun. 2023 (A$0.00 Mil) to Dec. 2023 (A$1.10 Mil).

Avecho Biotechnology's annual Other Current Receivables declined from Dec. 2021 (A$1.06 Mil) to Dec. 2022 (A$0.75 Mil) but then increased from Dec. 2022 (A$0.75 Mil) to Dec. 2023 (A$1.10 Mil).

Avecho Biotechnology Other Current Receivables Historical Data

The historical data trend for Avecho Biotechnology's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avecho Biotechnology Other Current Receivables Chart

Avecho Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Receivables

Get a 7-Day Free Trial

0.60

0.44

1.06

0.75

1.10

Avecho Biotechnology Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Receivables	Get a 7-Day Free Trial															1.06	-	0.75	-	1.10

Avecho Biotechnology Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Avecho Biotechnology Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Avecho Biotechnology's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Avecho Biotechnology (ASX:AVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avecho Biotechnology Ltd (ASX:AVE) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

OEZ:Germany

Address

Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168

Website

https://www.avecho.com.au

Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sale, and licensing of products incorporating its patented platform technology TPM, for the pharmaceutical, skincare and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.

Avecho Biotechnology (ASX:AVE) Headlines

No Headlines